B. Matija Peterlin
- Virology top 0.02%
- HIV Research and Treatment 105
- Immunology top 0.2%
- Immune Cell Function and Interaction 50
- T-cell and B-cell Immunology 40
- Immunotherapy and Immune Responses 15
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 47
- Molecular Biology top 0.5%
- RNA Research and Splicing 43
- RNA and protein synthesis mechanisms 18
- Genomics and Chromatin Dynamics 18
- Epidemiology top 1%
- Co-authors
- David H. PriceKoh FujinagaPaul A. LuciwMatjaž BarboričKatherine A. JonesO. FacklerMatthias GeyerS. Kanazawa
- Partner nations
- United StatesSloveniaGermany
In The Last Decade
B. Matija Peterlin
188 papers receiving 15.6k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Virology 7.8k
- Immunology 5.1k
- Infectious Diseases 3.6k
- Molecular Biology 8.3k
- Epidemiology 2.1k
Countries citing papers authored by B. Matija Peterlin
This map shows the geographic impact of B. Matija Peterlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Matija Peterlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Matija Peterlin more than expected).
Fields of papers citing papers by B. Matija Peterlin
This network shows the impact of papers produced by B. Matija Peterlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Matija Peterlin. The network helps show where B. Matija Peterlin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Matija Peterlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 70 | |
| 2 | 2022 | 6 | |
| 3 | 2020 | 4 | |
| 4 | 2019 | 7 | |
| 5 | 2018 | 17 | |
| 6 | 2018 | 17 | |
| 7 | 2017 | 37 | |
| 8 | 2012 | 154 | |
| 9 | 2008 | 40 | |
| 10 | 2007 | 122 | |
| 11 | Controlling the Elongation Phase of Transcription with P-TEFbbreakdown → | 2006 | 874 |
| 12 | 2005 | 41 | |
| 13 | 2002 | 84 | |
| 14 | 1999 | 71 | |
| 15 | 1998 | 218 | |
| 16 | 1997 | 145 | |
| 17 | 1996 | 43 | |
| 18 | 1993 | 22 | |
| 19 | 1992 | 20 | |
| 20 | 1990 | 3 |
About B. Matija Peterlin
B. Matija Peterlin is a scholar working on Virology, Immunology and Infectious Diseases, having authored 188 papers that have together received 15.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (105 papers), Immune Cell Function and Interaction (50 papers), HIV/AIDS drug development and treatment (47 papers), RNA Research and Splicing (43 papers), T-cell and B-cell Immunology (40 papers), RNA and protein synthesis mechanisms (18 papers), Genomics and Chromatin Dynamics (18 papers) and Immunotherapy and Immune Responses (15 papers). The work is most often cited by research in Virology (7.8k citations), Immunology (5.1k citations) and Infectious Diseases (3.6k citations). B. Matija Peterlin has collaborated with scholars based in United States, Slovenia and Germany. Frequent co-authors include David H. Price, Koh Fujinaga, Paul A. Luciw, Matjaž Barborič, Katherine A. Jones, O. Fackler, Matthias Geyer, S. Kanazawa, Yong‐Hui Zheng and Ran Taube.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.